|
|
Volumn 145, Issue 1, 1992, Pages 36-41
|
|
A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISONIAZID;
PLACEBO;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DRUG RESISTANCE;
DRUG SENSITIVITY;
GASTROINTESTINAL SYMPTOM;
HEPATITIS;
HONG KONG;
HUMAN;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
NEUROLOGIC DISEASE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SILICOSIS;
SKIN DISEASE;
TUBERCULOSIS;
VERTIGO;
|
|
EID: 0026541562
PISSN: 00030805
EISSN: None
Source Type: Journal
DOI: 10.1164/ajrccm/145.1.36 Document Type: Article |
|
Times cited : (305)
|
|
References (0)
|
